- People with spinal cord injuries suffer from paralysis and numbness
- Other complications include chronic pain and bladder dysfunction, that can be severe and disabling
- Human stem cell implants within the spinal cord may give relief from chronic pain and bladder problems.
- Quality of life for spinal injury patients will improve, as a result.
Human stem cell treatment in mice has been shown to alleviate what can be
considered the two most crippling effects of spinal cord injury, namely chronic
neuropathic pain and bladder dysfunction issues, in a recent study.
Lead Up To The StudyIt is believed that some of the complications following spinal cord injury may be due to a deficiency of inhibitory neurotransmitter gamma amino butyric acid (GABA) in the spinal cord. Using human embryonic stem cells capable of differentiating into medial ganglionic eminence (MGE)-like cells, which produce GABA, may help reduce the severe disability caused chronic pain and bladder dysfunction in such patients.
The investigators of this study employed precursors of GABAergic inhibitory neuron called MGE-like cells derived from human embryonic stem cells.
"We reasoned if we could take inhibitory neurons and directly place them into the spinal cord in the regions that are overactive, they might integrate into those circuits and suppress the activity," says Kriegstein.
Details Of The Study
The GABAergic neural precursor cells (MGE-like cells) were placed within the spinal cords of mice two weeks after inducing spinal injury, where they could differentiate into GABA-producing neurons and form synaptic connections.
"Rather than implanting these cells into the site of injury, at the mid-thoracic level, we injected them in the lumbosacral region, where the circuits are known to be overactive," says Thomas Fandel, a research specialist at UCSF and the study's co-first author. "Six months later we could see broad dispersion of the cells in that area. They were integrated into the spinal cord."
Testing The Efficacy Of Human Stem Cells In Mice
The researchers employed several methods to find out whether the stem cells were effective in alleviating neuropathic pain and bladder dysfunction at six months. To test for bladder control, the mice were placed in cages with filter paper to indicate where the mice had urinated. The transplanted mice had lesser, and bigger spots, indicating less leakage. Bladder function was also assessed by estimating bladder volume and tension, which validated the better voiding ability of animals receiving transplants.
Six months after transplant, animals exhibited markedly reduced pain sensitivities. Grooming and scratching behaviors were also evaluated, as decreased GABA in the spinal cord can also lead to a pathological itch (pruritus). The investigators found that mice receiving the stem cell transplants showed a reduced overgrooming compared to controls.
"The fact that these cells were implanted in the spinal cords two weeks after injury is also important to note," says Alpa Trivedi, a researcher at UCSF and co-first author of the study. "Many of the current Phase I trials for spinal cord injury are run in the acute phase, which is right after injury. But the vast majority of people with spinal cord injuries are the chronic patient population, and a treatment that might work for them would capture a larger number of patients who are really in need of better treatments."
About Spinal Injuries
Spinal cord injuries result from a sudden impact to the spine that may result in crushing or compression of the vertebrae.
Spinal injuries are usually characterized by paralysis and loss of sensation or numbness below the level of injury. The extent of injury determines the degree of paralysis and numbness.
Additional features include
- Occurrence of a chronic neuropathic pain related to nerve injury and damage,
- Loss of bladder and bowel control
- Increased vulnerability to respiratory infections
The quality of life for spinal injury patients thus remains challenging, even with treatment.
Scope Of This Study In Humans
Though more research needs to be done, the employment of human stem cells instead of mouse stem cells in their study is a step forward.
"Chronic pain and bladder dysfunction remain significant quality-of-life issues for many people with spinal cord injuries. Inhibitory cell-based neuro-therapy is a new approach and has shown promise to date in early animal studies, warranting further development," says Cory Nicholas, a co-first author.
In conclusion, the researchers hope that their work would result in a longer lasting or even a permanent solution to spinal injury patients, especially since the presently available modalities of treatment are not very satisfactory.